GERN – HedgeChatter

Geron Discontinues GRN1005 and Restructures to Focus on Imetelstat Development in Hematologic Malignancies and Solid Tumors with Short Telomeres

[at noodls] – Company to Host Conference Call at 8:30 a.m. ET on Tuesday, December 4 MENLO PARK, Calif., December 3, 2012 – Geron Corporation (Nasdaq: GERN) today announced that the company has discontinued development … moreView todays social media effects on GERNView the latest stocks trending across Twitter. Click to view dashboardSee who Geron is hiring next, click here […]

December 3, 2012 Bystocknews GERN, stock Comments Off read more

Geron Announces Non-Binding Letter of Intent with BioTime Regarding Stem Cell Assets

[at noodls] – MENLO PARK, Calif., November 15, 2012 — Geron Corporation (Nasdaq: GERN) today announced that the company has entered into a non-binding letter of intent (LOI) with BioTime, Inc. (NYSE: BTX) and BioTime’s … moreView todays social media effects on GERNView the latest stocks trending across Twitter. Click to view dashboard […]

November 15, 2012 Bystocknews GERN, stock Comments Off read more

PropThink: Geron Q3 Earnings Review: Waiting Not for Godot, but for San Antonio and Atlanta

[ACN Newswire] – By Ivan DeryuginWhen a biotechnology company is around 20 years after its incorporation, common wisdom would suggest that it has become a major player in the biotechnology sector, with at least one blockbuster … moreView todays social media effects on GERNView the latest stocks trending across Twitter. Click to view dashboard […]

November 5, 2012 Bystocknews GERN, stock Comments Off read more

Geron Corporation Reports 2012 Third Quarter Financial Results and Events

[at noodls] – MENLO PARK, Calif., October 30, 2012 — Geron Corporation (Nasdaq: GERN) today reported financial results for the three and nine months ended September 30, 2012….This is an abstract of the original noodl. … moreView todays social media effects on GERNView the latest stocks trending across Twitter. Click to view dashboard […]

October 30, 2012 Bystocknews GERN, stock Comments Off read more

Geron Announces Conference Call to Discuss Third Quarter 2012 Financial Results

[at noodls] – Menlo Park, Calif., October 23, 2012 – Geron Corporation (Nasdaq: GERN) will announce its financial results for the third quarter ended September 30, 2012 on Tuesday, October 30, 2012, after the market … moreView todays social media effects on GERNView the latest stocks trending across Twitter. Click to view dashboard […]

October 23, 2012 Bystocknews GERN, stock Comments Off read more

Geron Acknowledges Letter to its Stockholders from BioTime

[at noodls] – MENLO PARK, Calif., October 19, 2012 — Geron Corporation (Nasdaq: GERN) today acknowledged the public release by BioTime, Inc. (NYSE: BTX) of a letter to Geron’s stockholders regarding Geron’s stem cell … moreView todays social media effects on GERNView the latest stocks trending across Twitter. Click to view dashboard […]

October 19, 2012 Bystocknews GERN, stock Comments Off read more

PropThink: Stem Cell Divestiture May Benefit Geron Shareholders More than the Company

[ACN Newswire] – By Jake KingGeron Corp (NASDAQ:GERN) may have finally found a buyer for its suspended stem cell program. The company has been searching since November of 2011 when Geron halted the projects to focus on … moreView todays social media effects on GERNView the latest stocks trending across Twitter. Click to view dashboard […]

October 18, 2012 Bystocknews GERN, stock Comments Off read more

Geron Appoints Susan Molineaux and Daniel Bradbury to Board of Directors

[at noodls] – MENLO PARK, Calif., September 28, 2012 – Geron Corporation (Nasdaq: GERN) today announced the appointment of Susan M. Molineaux, Ph.D., and Daniel M. Bradbury to its board of directors. Dr. Molineaux is … moreView todays social media effects on GERNView the latest stocks trending across Twitter. Click to view dashboard […]

September 28, 2012 Bystocknews GERN, stock Comments Off read more